SCHEMBL21242001

SCHEMBL21242001

CCCCN1C(=O)c2cccc3c(Cl)ccc(c23)C1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ LMNA P02545 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.48
▸ POLB P06746 3/20 0.47
▸ MAPT P10636 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ ERCC1 P07992 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ FEN1 P39748 1/20 0.47
▸ ERCC4 Q92889 1/20 0.47
▸ ALOX15 P16050 1/20 0.43
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ RGS12 O14924 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23340532 0.78 MEN1 (0.49) KDM4EALDH1A1LMNAL3MBTL1POLB
SCHEMBL12939880 0.77 L3MBTL1 (0.58) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL27960801 0.77 L3MBTL1 (0.58) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL6887733 0.77 ALDH1A1 (0.74) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL19976649 0.73 L3MBTL1 (0.57) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL20385853 0.72 BRD4 (0.41) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL7632891 0.72 L3MBTL1 (0.56) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL11932614 0.72 ALDH1A1 (0.70) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL3888669 0.72 ALDH1A1 (0.70) KDM4EALDH1A1LMNAHPGDL3MBTL1
SCHEMBL20392828 0.71 STAT3 (0.48) KDM4EALDH1A1LMNAL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10851185-B2 Bonding tissues and cross-linking proteins with naphthalimide compounds ALUMEND, LLC (US) 2020-12-01 — — US disclosed
US-20190241680-A1 Bonding tissues and cross-linking proteins with naphthalimide compounds ALUMEND, LLC (US) 2019-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851185-B2 Bonding tissues and cross-linking proteins with naphthalimide compounds BMP2, SUN2, TAGLN2 KDM4E 2869/4885ALDH1A1 1456/4885LMNA 383/4885
US-20190241680-A1 Bonding tissues and cross-linking proteins with naphthalimide compounds BMP2, SUN2, TAGLN2 KDM4E 2869/4885ALDH1A1 1456/4885LMNA 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback